LAB
Price
$1.29
Change
-$0.02 (-1.53%)
Updated
Sep 25 closing price
Capitalization
492.77M
46 days until earnings call
QTRX
Price
$5.26
Change
-$0.04 (-0.75%)
Updated
Sep 25 closing price
Capitalization
244.41M
40 days until earnings call
Interact to see
Advertisement

LAB vs QTRX

Header iconLAB vs QTRX Comparison
Open Charts LAB vs QTRXBanner chart's image
Standard BioTools
Price$1.29
Change-$0.02 (-1.53%)
Volume$1.26M
Capitalization492.77M
Quanterix
Price$5.26
Change-$0.04 (-0.75%)
Volume$299.09K
Capitalization244.41M
LAB vs QTRX Comparison Chart in %
Loading...
LAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QTRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LAB vs. QTRX commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LAB is a StrongBuy and QTRX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (LAB: $1.29 vs. QTRX: $5.28)
Brand notoriety: LAB and QTRX are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: LAB: 58% vs. QTRX: 17%
Market capitalization -- LAB: $492.77M vs. QTRX: $244.41M
LAB [@Medical/Nursing Services] is valued at $492.77M. QTRX’s [@Medical/Nursing Services] market capitalization is $244.41M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $232.02B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.52B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LAB’s FA Score shows that 1 FA rating(s) are green whileQTRX’s FA Score has 1 green FA rating(s).

  • LAB’s FA Score: 1 green, 4 red.
  • QTRX’s FA Score: 1 green, 4 red.
According to our system of comparison, LAB is a better buy in the long-term than QTRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LAB’s TA Score shows that 5 TA indicator(s) are bullish while QTRX’s TA Score has 5 bullish TA indicator(s).

  • LAB’s TA Score: 5 bullish, 4 bearish.
  • QTRX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both LAB and QTRX are a good buy in the short-term.

Price Growth

LAB (@Medical/Nursing Services) experienced а -8.16% price change this week, while QTRX (@Medical/Nursing Services) price change was -5.38% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.09%. For the same industry, the average monthly price growth was +2.86%, and the average quarterly price growth was +9.05%.

Reported Earning Dates

LAB is expected to report earnings on Nov 11, 2025.

QTRX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Medical/Nursing Services (-2.09% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LAB($493M) has a higher market cap than QTRX($244M). LAB YTD gains are higher at: -26.000 vs. QTRX (-50.329). QTRX has higher annual earnings (EBITDA): -72.89M vs. LAB (-120.98M). QTRX has more cash in the bank: 261M vs. LAB (237M). LAB has less debt than QTRX: LAB (28.6M) vs QTRX (35.5M). LAB has higher revenues than QTRX: LAB (172M) vs QTRX (124M).
LABQTRXLAB / QTRX
Capitalization493M244M202%
EBITDA-120.98M-72.89M166%
Gain YTD-26.000-50.32952%
P/E RatioN/AN/A-
Revenue172M124M139%
Total Cash237M261M91%
Total Debt28.6M35.5M81%
FUNDAMENTALS RATINGS
LAB vs QTRX: Fundamental Ratings
LAB
QTRX
OUTLOOK RATING
1..100
129
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
27
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9796
PRICE GROWTH RATING
1..100
5063
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
9050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QTRX's Valuation (27) in the Pharmaceuticals Major industry is in the same range as LAB (32) in the Medical Specialties industry. This means that QTRX’s stock grew similarly to LAB’s over the last 12 months.

QTRX's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as LAB (100) in the Medical Specialties industry. This means that QTRX’s stock grew similarly to LAB’s over the last 12 months.

QTRX's SMR Rating (96) in the Pharmaceuticals Major industry is in the same range as LAB (97) in the Medical Specialties industry. This means that QTRX’s stock grew similarly to LAB’s over the last 12 months.

LAB's Price Growth Rating (50) in the Medical Specialties industry is in the same range as QTRX (63) in the Pharmaceuticals Major industry. This means that LAB’s stock grew similarly to QTRX’s over the last 12 months.

LAB's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as QTRX (100) in the Pharmaceuticals Major industry. This means that LAB’s stock grew similarly to QTRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LABQTRX
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
87%
Momentum
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
85%
MACD
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 11 days ago
81%
Bullish Trend 11 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
80%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
LAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QTRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JMCEX63.66N/A
N/A
JPMorgan Mid Cap Equity R2
MGKIX15.07N/A
N/A
Morgan Stanley Global Permanence I
REQTX48.06N/A
N/A
Russell Sustnbl Aware Eq S
ARREX26.23N/A
N/A
American Century Real Estate R5
JSCHX34.14N/A
N/A
JPMorgan Small Cap Blend R6

LAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, LAB has been loosely correlated with TMCI. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if LAB jumps, then TMCI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LAB
1D Price
Change %
LAB100%
-1.15%
TMCI - LAB
44%
Loosely correlated
-1.47%
ENOV - LAB
44%
Loosely correlated
-3.96%
CTKB - LAB
43%
Loosely correlated
-0.29%
CLPT - LAB
43%
Loosely correlated
+2.44%
QTRX - LAB
42%
Loosely correlated
-0.38%
More

QTRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, QTRX has been loosely correlated with ILMN. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if QTRX jumps, then ILMN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QTRX
1D Price
Change %
QTRX100%
-0.38%
ILMN - QTRX
50%
Loosely correlated
-2.38%
TWST - QTRX
49%
Loosely correlated
-1.00%
BLFS - QTRX
44%
Loosely correlated
+0.37%
A - QTRX
43%
Loosely correlated
-2.03%
AZTA - QTRX
43%
Loosely correlated
-3.56%
More